← Eichor
Study identifier: NCT02280889 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Condition: Quality of Life · Stigmatization  ·  Sponsor: University Children's Hospital, Zurich

PhaseN/A
Planned participants100
Who can joinAll sexes, 9 Months to 16 Years
Healthy volunteersNo

About this study

Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Kathrin Neuhaus, MD  ·  +41442497466  ·  kathrin.neuhaus@kispi.uzh.ch

Markus Landolt, Prof  ·  +41442496388  ·  markus.landolt@kispi.uzh.ch

Always discuss trial participation with your own doctor first.

Locations (1)

University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive SurgeryZurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02280889